Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
253
-
Total 13F shares, excl. options
-
38.3M
-
Shares change
-
-474K
-
Total reported value, excl. options
-
$3.06B
-
Value change
-
-$38.3M
-
Put/Call ratio
-
1.15
-
Number of buys
-
134
-
Number of sells
-
-99
-
Price
-
$79.80
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2024
307 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.3M shares
of 48.9M outstanding shares and own 78.36% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.49M shares), VANGUARD GROUP INC (3.74M shares), BlackRock Inc. (3.2M shares), Fairmount Funds Management LLC (2.36M shares), Deep Track Capital, LP (1.3M shares), CITADEL ADVISORS LLC (1.14M shares), PERCEPTIVE ADVISORS LLC (1.11M shares), RA CAPITAL MANAGEMENT, L.P. (1M shares), MORGAN STANLEY (944K shares), and STATE STREET CORP (939K shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.